Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: GRAMMER designates two new candidates for the Supervisory Board : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24104/266px-Grammer_AG_Logo.svg.png
DGAP-News: GRAMMER designates two new candidates for the Supervisory Board
DGAP-News: GRAMMER designates two new candidates for the Supervisory Board
Pfizer Names David M. Denton Chief Financial Officerhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Names David M. Denton Chief Financial Officer


Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as Chief Financial Officer (CFO) and Executive Vice President effective May 2, 2022. Mr. Denton will be a member

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
DGAP-News: GEA and its staff donate EUR 250,000 in aid to Ukraine: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23714/375px-GEA_Group_2010_logo.svg.png
DGAP-News: GEA and its staff donate EUR 250,000 in aid to Ukraine
DGAP-News: GEA and its staff donate EUR 250,000 in aid to Ukraine
DGAP-News: CureVac and GSK Enter into Pandemic Preparedness Contract with German  Government : https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
DGAP-News: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government
DGAP-News: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government
DGAP-News: INDUS Holding AG: Press release on the closing of Heiber + Schröder Maschinenbau GmbH: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24113/Indus_Holding_AG_Logo.svg.png
DGAP-News: INDUS Holding AG: Press release on the closing of Heiber + Schröder Maschinenbau GmbH
DGAP-News: INDUS Holding AG: Press release on the closing of Heiber + Schröder Maschinenbau GmbH
Nordea Bank Abp: Repurchase of own shares on 08.04.2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
Nordea Bank Abp: Repurchase of own shares on 08.04.2022
Nordea Bank Abp: Repurchase of own shares on 08.04.2022
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F


Regulatory News:



NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities

IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg
IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting


IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today

AIG to Redeem 1.500% Notes Due 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23883/AIG_logo.svg.png
AIG to Redeem 1.500% Notes Due 2023


American International Group, Inc. (NYSE: AIG) today announced that it will redeem all of its outstanding 1.500% Notes Due 2023 (Common Code 140578142 / ISIN XS1405781425) (the “Notes”) on May 10

ProAssurance Corporation Announces Dates for First Quarter 2022 Results Release and Conference Call: https://mms.businesswire.com/media/20200902005913/en/154261/5/ProAssurance_Logo_HiRes.jpg
ProAssurance Corporation Announces Dates for First Quarter 2022 Results Release and Conference Call


ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2022 after the close of normal New York Stock Exchange trading on Monday, May 9, 2022.



ProAssurance will

Negro Leagues Baseball Museum and First Business Bank Announce Partnership to Help “Coin the Legacy” of the Negro Leagues: https://mms.businesswire.com/media/20200123005785/en/686659/5/Fb_logo.jpg
Negro Leagues Baseball Museum and First Business Bank Announce Partnership to Help “Coin the Legacy” of the Negro Leagues


The Negro Leagues Baseball Museum (NLBM) announced today an exciting partnership with First Business Bank to become the “Official Bank” of the United States Mint Negro Leagues Commemorative Coins

NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of over 125 studies enabled by

DGAP-News: Delivery Hero successfully completes syndication of EUR 1.4 billion-equivalent debt financing: https://www.deliveryhero.com/newsroom/downloads/
DGAP-News: Delivery Hero successfully completes syndication of EUR 1.4 billion-equivalent debt financing
DGAP-News: Delivery Hero successfully completes syndication of EUR 1.4 billion-equivalent debt financing
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will present additional positive

Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the

AbCellera Presents Data on T Cell Engager Platform at AACR 2022: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg
AbCellera Presents Data on T Cell Engager Platform at AACR 2022


AbCellera (Nasdaq: ABCL), a technology company focused on next-generation antibody discovery, today announced the release of data on its new T cell engager platform at the American Association for

For Canadian Mainframe Users, Cloud is the Goal: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
For Canadian Mainframe Users, Cloud is the Goal


Mainframes are prime targets for digital transformation at many Canadian enterprises that want to increase data access, agility and automation, according to a new research report published today by

Mainframe-to-Cloud Migration Poised to Unlock Data: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Mainframe-to-Cloud Migration Poised to Unlock Data


Recent advances in tools for migrating legacy applications to the cloud have altered the mainframe market, but so far, few U.S. enterprises have adopted them, according to a new research report

DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23691/Alstria-office-REIT-Logo.svg.png
DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders
DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures


LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the

Guess?, Inc. Files Definitive Proxy Materials and Investor Presentation: https://mms.businesswire.com/media/20191204005915/en/760670/5/GUESS_ECO_TRIANGLE.jpg
Guess?, Inc. Files Definitive Proxy Materials and Investor Presentation


Guess?, Inc. (NYSE: GES) (“Guess” or the “Company”) today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission (“SEC”) as well as an investor

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari: https://mms.businesswire.com/media/20210517005319/en/809100/5/fsd_logo_black_molecule_color.jpg
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari


FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced

Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022:
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022


Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting

Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022


Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that two abstracts featuring non-clinical data from studies evaluating FAP-2286 and Rubraca and a Trial-in-Progress poster detailing the Phase